4-(3-Nitrophenyl)-1,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazin-2-amine

Catalog No. :
ACTVYH087
CAS No. :
78650-05-2
Molecular Formula :
C15H12N6O2
Molecular Weight :
308.30

IUPAC Name:4-(3-nitrophenyl)-1,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazin-2-amine

4-(3-Nitrophenyl)-1,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazin-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(3-Nitrophenyl)-1,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazin-2-amine
IUPAC Name4-(3-nitrophenyl)-1,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazin-2-amine
Molecular FormulaC15H12N6O2
Molecular Weight308.30
SMILESNC(N1)=NC(C2=CC([N+]([O-])=O)=CC=C2)N3C1=NC4=CC=CC=C43
InChI KeyMKPGPLNWEGNLML-UHFFFAOYSA-N
Synonym4-(3-nitrophenyl)-4,10-dihydro-[1,3,5]triazino[1,2-a]benzimidazol-2-amine;WAY-605849;1,3,5-Triazino[1,2-a]benzimidazol-2-amine, 1,4-dihydro-4-(3-nitrophenyl)-;4-(3-Nitro-phenyl)-3,4-dihydro-benzo[4,5]imidazo[1,2-a][1,3,5]triazin-2-ylamine
CAS No.78650-05-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTVYH087 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWYJN923 route compound structure diagram
    ACWYJN9235418-95-1 In Stock
  2. Plus
  3. ACARYC439 route compound structure diagram
    ACARYC43999-61-6 In Stock
  4. Then
  5. ACTVYH087 route product structure diagram
    ACTVYH08778650-05-2
Inquiry

2. ACTVYH087 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTVYH087 route product structure diagram
    ACTVYH08778650-05-2
Inquiry

Comments (0)